Notably, Ou Yang et al41 went on to suggest that breast cancer subtype classification as well as hormone receptor and HER2 status did not add additional prognostic information when expression levels of the FGD3-SUSD3 metagene and the attractor metagenes were known and taken into consideration. The gene discussed is ERBB2; the disease is breast cancer.